Sophoridine

Catalog No.S3895 Batch:S389501

Print

Technical Data

Formula

C15H24N2O
Molecular Weight 248.36 CAS No. 6882-68-4
Solubility (25°C)* In vitro DMSO 49 mg/mL (197.29 mM)
 
 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Sophoridine (5-Epidihydrosophocarpine, Dihydro-5-episophocarpine), a natural product obtained from medicinal plants, has a variety of pharmacological effects, including anti-cancer and anti-arrhythmia, and affects the immune and central nervous systems.
In vitro Sophoridine kills cancer cells but has low cytotoxicity to normal cells. Pancreatic cancer cells are particularly sensitive. Sophoridine inhibits the proliferation of pancreatic cancer cells and induces cell cycle arrest at S phase and mitochondrial-related apoptosis. Moreover, Sophoridine induces a sustained activation of the phosphorylation of ERK and JNK. In addition, Sophoridine provokes the generation of reactive oxygen species (ROS) in pancreatic cancer cells[1]. Sophoridine also triggers significant down-regulated the expression of p27, CDK2, Survivin, Livin, Bcl-2, E2F1 and the transcriptional activity of FoxM1, NF-κb and AP-1, meanwhile, up-regulated the expression of caspase-3/8, p53, Smac, c-JNK and p38-MAPK. Sophoridine significantly inhibits ubiquitin-proteasome in tumor cells[2].
In vivo Sophoridine is an effective agent that can inhibit the growth of xenograft pancreatic tumors in vivo with well-tolerated toxicity[1]. Sophoridine attenuates intestinal inflammation in the experimental colitis model, which is associated with the downregulation of ICAM-1 gene expression[3].

Protocol (from reference)

Cell Assay:[1]
  • Cell lines

    Miapaca-2 and PANC-1; HPDE

  • Concentrations

    0, 10, 20, 40, 80, or 100 μM

  • Incubation Time

    24 h, 48 h, or 72 h

  • Method

    Two human pancreatic cancer cell lines (Miapaca-2 and PANC-1) and pancreatic ductal epithelial cell line (HPDE) are treated with Sophoridine at different concentrations (0, 10, 20, 40, 80, or 100 μM) for different lengths of time (24 h, 48 h, or 72 h). Cell viability is determined by the CCK-8 assay.
Animal Study:[1]
  • Animal Models

    BALB/c homozygous (nu/nu) nude mice (6 weeks, 18 g)

  • Dosages

    20 mg/kg or 40 mg/kg

  • Administration

    i.p.

Selleck's Sophoridine has been cited by 1 publication

Sophoridine suppresses lenvatinib-resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression [ J Cell Mol Med, 2020, 10.1111/jcmm.16108] PubMed: 33210432

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.